Monocyte and myeloid dendritic cell activation occurs throughout HIV type 2 infection, an attenuated form of HIV disease

Journal of Infectious Diseases

Volumn 207, Issue 11, 2013, Pages 1730-1742

  Cavaleiro, Rita ^a   Tendeiro, Rita ^a   Foxall, Russell B ^a   Soares, Rui S ^a   Baptista, António P ^a   Gomes, Perpétua ^b,c,e   Valadas, Emília ^d   Victorino, Rui M M ^a,d   Sousa, Ana E ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b HOSPITAL EGAS MONIZ   (Portugal)

^c INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^d HOSPITAL DE SANTA MARIA   (Portugal)

^e INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

Author keywords

AIDS; HIV 2; Immune Activation; Monocytes; Myeloid Dendritic Cells; PD L1

Indexed keywords

ANTIRETROVIRUS AGENT; CD14 ANTIGEN; CD16 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; CELL ACTIVATION; CELL EXPANSION; CELL LOSS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MYELOID DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; RESERVOIR; T CELL DEPLETION; UPREGULATION; VIREMIA;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD274; DENDRITIC CELLS; FEMALE; HIV INFECTIONS; HIV-2; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MONOCYTES; YOUNG ADULT;

EID: 84877298095     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit085     Document Type: Article

References (50)

1. Grossman Z, Meier-Schellersheim M, Sousa AE, Victorino RM, Paul WE. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat Med 2002; 8:319-23.
2. Coleman CM, Wu L. HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 2009; 6:51.
3. Ancuta P, Kamat A, Kunstman KJ, et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 2008; 3:e2516.
4. Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, Haeffner-Cavaillon N. CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 1995; 25:3418-24.
5. Dutertre CA, Amraoui S, Derosa A, et al. Pivotal role of M-DC8+ monocytes from viremic HIV-infected patients in TNFalpha over-production in response to microbial products. Blood 2012; 120:2259-68.
6. Hearps AC, Maisa A, Cheng WJ, et al. HIV infection induces agerelated changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS 2012; 26:843-53.
7. Ellery PJ, Tippett E, Chiu YL, et al. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 2007; 178:6581-9.
8. Jaworowski A, Kamwendo DD, Ellery P, et al. CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection. J Infect Dis 2007; 196:38-42.
9. Cheong C, Matos I, Choi JH, et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 2010; 143:416-29.
10. Barron MA, Blyveis N, Palmer BE, MaWhinney S, Wilson CC. Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J Infect Dis 2003; 187:26-37.
11. Dillon SM, Friedlander LJ, Rogers LM, et al. Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study. J Virol 2011; 85:397-409.
12. Grassi F, Hosmalin A, McIlroy D, Calvez V, Debre P, Autran B. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS 1999; 13:759-66.
13. Poulsen AG, Aaby P, Larsen O, et al. 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa. Lancet 1997; 349:911-4.
14. Popper SJ, Sarr AD, Gueye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J Virol 2000; 74:1554-7.
15. Soares RS, Tendeiro R, Foxall RB, et al. Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients. J Virol 2011; 85:2429-38.
16. Carvalho AC, Valadas E, Franca L, et al. Population mobility and the changing epidemics of HIV-2 in Portugal. HIV Med 2012; 13:219-25.
17. de Silva TI, Cotten M, Rowland-Jones SL. HIV-2: the forgotten AIDS virus. Trends Microbiol 2008; 16:588-95.
18. Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 2002; 169:3400-6.
19. Drylewicz J, Matheron S, Lazaro E, et al. Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France. AIDS 2008; 22:457-68.
20. Duvall MG, Lore K, Blaak H, et al. Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection. J Virol 2007; 81:13486-98.
21. Laguette N, Sobhian B, Casartelli N, et al. SAMHD1 is the dendriticand myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011; 474:654-7.
22. Chougnet C, Gessani S. Role of gp120 in dendritic cell dysfunction in HIV infection. J Leukoc Biol 2006; 80:994-1000.
23. Cavaleiro R, Baptista AP, Foxall RB, Victorino RM, Sousa AE. Dendritic cell differentiation and maturation in the presence of HIV type 2 envelope. AIDS Res Hum Retroviruses 2009; 25:425-31.
24. Cavaleiro R, Sousa AE, Loureiro A, Victorino RM. Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity. AIDS 2000; 14:2679-86.
25. Cavaleiro R, Brunn GJ, Albuquerque AS, Victorino RM, Platt JL, Sousa AE. Monocyte-mediated T cell suppression by HIV-2 envelope proteins. Eur J Immunol 2007; 37:3435-44.
26. Okulicz JF, Lambotte O. Epidemiology and clinical characteristics of elite controllers. Curr Opin HIVAIDS 2011; 6:163-8.
27. Cavaleiro R, Baptista AP, Soares RS, et al. Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease. PLoS Pathog 2009; 5:e1000667.
28. Barbosa RR, Silva SP, Silva SL, et al. Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels. Clin Exp Immunol 2012; 169:263-72.
29. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-71.
30. Soriano V, Gomes P, Heneine W, et al. Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J Med Virol 2000; 61:111-6.
31. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116:e74-80.
32. Cros J, Cagnard N, Woollard K, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010; 33:375-86.
33. Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 1991; 147:1567-74.
34. Sandler NG,Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011; 203:780-90.
35. Thiebaut R, Charpentier C, Damond F, et al. Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression. Clin Infect Dis 2012; 55:1417-25.
36. Hrecka K, Hao C, Gierszewska M, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011; 474:658-61.
37. Goujon C, Arfi V, Pertel T, et al. Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells. J Virol 2008; 82:12335-45.
38. Stec M, Weglarczyk K, Baran J, et al. Expansion and differentiation of CD14+CD16(-) and CD14+ +CD16+ human monocyte subsets from cord blood CD34+ hematopoietic progenitors. J Leukoc Biol 2007; 82:594-602.
39. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81:584-92.
40. Nowroozalizadeh S, Mansson F, da Silva Z, et al. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis 2010; 201:1150-4.
41. Kaufmann A, Gemsa D, Sprenger H. Differential desensitization of lipopolysaccharide-inducible chemokine gene expression in human monocytes and macrophages. Eur J Immunol 2000; 30:1562-7.
42. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 1997; 27:431-41.
43. Tendeiro R, Foxall RB, Baptista AP, et al. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia. AIDS 2012; 26:1065-71.
44. Jobe O, Ariyoshi K, Marchant A, et al. Proviral load and immune function in blood and lymph node during HIV-1 and HIV-2 infection. Clin Exp Immunol 1999; 116:474-8.
45. Schramm B, Penn ML, Palacios EH, Grant RM, Kirchhoff F, Goldsmith MA. Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1. J Virol 2000; 74:9594-600.
46. Goujon C, Riviere L, Jarrosson-Wuilleme L, et al. SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology 2007; 4:2.
47. Manel N, Littman DR. Hiding in plain sight: how HIV evades innate immune responses. Cell 2011; 147:271-4.
48. Reeves JD, Doms RW. Human immunodeficiency virus type 2. J Gen Virol 2002; 83:1253-65.
49. Redd AD, Dabitao D, Bream JH, et al. Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci USA 2009; 106:6718-23.
50. Said EA, Dupuy FP, Trautmann L, et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 2010; 16:452-9.